BRISTOL-MYERS SQUIBB COMPANY Defined Contribution Plan, Cost
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Defined Contribution Plan, Cost of $325.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-02-11
- BRISTOL-MYERS SQUIBB COMPANY defined contribution plan, cost for the quarter ending 2020-12-31 was $70.00M, a 16.67% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY defined contribution plan, cost for the quarter ending 2020-09-30 was $70.00M, a 40.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY defined contribution plan, cost for the quarter ending 2020-06-30 was $65.00M, a 30.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY defined contribution plan, cost for the quarter ending 2020-03-31 was $85.00M, a 112.50% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY defined contribution plan, cost for fiscal 2025 was $325.00M, a 17.72% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY defined contribution plan, cost for fiscal 2024 was $395.00M, a 3.95% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY defined contribution plan, cost for fiscal 2023 was $380.00M, a 5.56% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY defined contribution plan, cost for fiscal 2022 was $360.00M, a 2.86% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 3 month as first filed | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 9 month as first filed | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $325.00M 10-K · filed 2026-02-11 | ||||||
| 2024-12-31 | $395.00M 10-K · filed 2026-02-11 | ||||||
| 2023-12-31 | $380.00M 10-K · filed 2026-02-11 | ||||||
| 2022-12-31 | $360.00M 10-K · filed 2025-02-12 | ||||||
| 2021-12-31 | $350.00M 10-K · filed 2024-02-13 | ||||||
| 2020-12-31 | $70.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $140.00M derived: sum of 2 quarters · filed 2023-02-14 | $205.00M derived: sum of 3 quarters · filed 2023-02-14 | $290.00M 10-K · filed 2023-02-14 | |||
| 2020-09-30 | $70.00M 10-Q · filed 2020-11-05 | $135.00M derived: sum of 2 quarters · filed 2020-11-05 | $220.00M 10-Q · filed 2020-11-05 | $280.00M derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-06-30 | $65.00M 10-Q · filed 2020-08-06 | $150.00M 10-Q · filed 2020-08-06 | $210.00M derived: sum of 3 quarters · filed 2022-02-09 | $260.00M derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-03-31 | $85.00M 10-Q · filed 2020-05-07 | $145.00M derived: sum of 2 quarters · filed 2022-02-09 | $195.00M derived: sum of 3 quarters · filed 2022-02-09 | $245.00M derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2019-12-31 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $110.00M derived: sum of 2 quarters · filed 2022-02-09 | $160.00M derived: sum of 3 quarters · filed 2022-02-09 | $200.00M 10-K · filed 2022-02-09 | |||
| 2019-09-30 | $50.00M 10-Q · filed 2020-11-05 | $100.00M derived: sum of 2 quarters · filed 2020-11-05 | $140.00M 10-Q · filed 2020-11-05 | $210.00M derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-06-30 | $50.00M 10-Q · filed 2020-08-06 | $90.00M 10-Q · filed 2020-08-06 | $160.00M derived: sum of 3 quarters · filed 2021-02-10 | $210.00M derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-03-31 | $40.00M 10-Q · filed 2020-05-07 | $110.00M derived: sum of 2 quarters · filed 2021-02-10 | $160.00M derived: sum of 3 quarters · filed 2021-02-10 | $210.00M derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2018-12-31 | $70.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $120.00M derived: sum of 2 quarters · filed 2021-02-10 | $170.00M derived: sum of 3 quarters · filed 2021-02-10 | $200.00M 10-K · filed 2021-02-10 | |||
| 2018-09-30 | $50.00M 10-Q · filed 2019-10-31 | $49.00M 10-Q · filed 2018-10-25 | $100.00M derived: sum of 2 quarters · filed 2019-10-31 | $130.00M 10-Q · filed 2019-10-31 | $134.00M 10-Q · filed 2018-10-25 | $198.00M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $50.00M 10-Q · filed 2019-07-25 | $47.00M 10-Q · filed 2018-07-26 | $90.00M 10-Q · filed 2019-07-25 | $148.00M derived: sum of 3 quarters · filed 2020-02-24 | $194.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $40.00M 10-Q · filed 2019-04-25 | $98.00M derived: sum of 2 quarters · filed 2020-02-24 | $144.00M derived: sum of 3 quarters · filed 2020-02-24 | $196.00M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $104.00M derived: sum of 2 quarters · filed 2020-02-24 | $156.00M derived: sum of 3 quarters · filed 2020-02-24 | $200.00M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $46.00M 10-Q · filed 2018-10-25 | $98.00M derived: sum of 2 quarters · filed 2018-10-25 | $142.00M 10-Q · filed 2018-10-25 | $197.00M derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2017-06-30 | $52.00M 10-Q · filed 2018-07-26 | $96.00M 10-Q · filed 2017-07-27 | $151.00M derived: sum of 3 quarters · filed 2019-02-25 | $200.00M derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2017-03-31 | $40.00M 10-Q · filed 2018-04-26 | $44.00M 10-Q · filed 2017-04-27 | $99.00M derived: sum of 2 quarters · filed 2019-02-25 | $148.00M derived: sum of 3 quarters · filed 2019-02-25 | $198.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2016-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $108.00M derived: sum of 2 quarters · filed 2019-02-25 | $158.00M derived: sum of 3 quarters · filed 2019-02-25 | $200.00M 10-K · filed 2019-02-25 | $190.00M 10-K · filed 2017-02-21 | ||
| 2016-09-30 | $49.00M 10-Q · filed 2017-10-26 | $99.00M derived: sum of 2 quarters · filed 2017-10-26 | $141.00M 10-Q · filed 2017-10-26 | $199.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | $50.00M 10-Q · filed 2017-07-27 | $92.00M 10-Q · filed 2017-07-27 | $150.00M derived: sum of 3 quarters · filed 2018-02-13 | $203.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | $42.00M 10-Q · filed 2017-04-27 | $100.00M derived: sum of 2 quarters · filed 2018-02-13 | $153.00M derived: sum of 3 quarters · filed 2018-02-13 | $198.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | $58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $111.00M derived: sum of 2 quarters · filed 2018-02-13 | $156.00M derived: sum of 3 quarters · filed 2018-02-13 | $200.00M 10-K · filed 2018-02-13 | $190.00M 10-K · filed 2016-02-12 | ||
| 2015-09-30 | $53.00M 10-Q · filed 2016-10-27 | $98.00M derived: sum of 2 quarters · filed 2016-10-27 | $142.00M 10-Q · filed 2016-10-27 | $191.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | $45.00M 10-Q · filed 2016-07-28 | $89.00M 10-Q · filed 2016-07-28 | $138.00M derived: sum of 3 quarters · filed 2017-02-21 | $183.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $44.00M 10-Q · filed 2016-04-28 | $93.00M derived: sum of 2 quarters · filed 2017-02-21 | $138.00M derived: sum of 3 quarters · filed 2017-02-21 | $184.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $94.00M derived: sum of 2 quarters · filed 2017-02-21 | $140.00M derived: sum of 3 quarters · filed 2017-02-21 | $190.00M 10-K · filed 2017-02-21 | |||
| 2014-09-30 | $45.00M 10-Q · filed 2015-10-27 | $91.00M derived: sum of 2 quarters · filed 2015-10-27 | $141.00M 10-Q · filed 2015-10-27 | ||||
| 2014-06-30 | $46.00M 10-Q · filed 2015-07-23 | $96.00M 10-Q · filed 2015-07-23 | |||||
| 2014-03-31 | $50.00M 10-Q · filed 2015-04-28 | ||||||
| 2013-12-31 | $190.00M 10-K · filed 2016-02-12 | ||||||
| 2012-12-31 | $190.00M 10-K · filed 2015-02-13 | ||||||
| 2011-12-31 | $181.00M 10-K · filed 2014-02-14 | ||||||
| 2010-12-31 | $188.00M 10-K · filed 2013-02-15 | ||||||
| 2009-12-31 | $50.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |